Policyholder Services

Will my OMIC policy cover me for using Restylane?

On December 12, 2003, Medicis received FDA approval to market Restylane in the United States. In recognition of the filler’s FDA approval status, OMIC will extend coverage to physicians who use Restylane for the correction of facial wrinkles and/or lip augmentation. OMIC also offers a sample Restylane consent form, developed by Dr. John Shore, a member of OMIC’s Underwriting and Risk Management Committees and practicing oculoplastic surgeon.

Click here for sample Consent for Restylane Injection form.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.